Carcinoembryonic antigen (CEA), a membrane glycoprotein with a molecular mass of about 180,000, originally described in 1965 as a tumour-associated colon cancer antigen (Gold & Freeman, 1965) , is now widely used in clinical practice as a tumour marker. Several other closely related glycoproteins have been isolated from various human tissues and faeces (Kuroki, 1981; Zimmerman, 1987; Cournoyer, 1988) , constituting what are now called the CEA related antigens.
The cDNA clones for CEA (Zimmerman, 1987; Oikawa, 1987; Kamarck, 1987; Beauchemin, 1987) and NCA (Neumaier, 1988; Tawaragi, 1988; Cournoyer, 1988) have been isolated and characterised. These led to several studies on the expression of CEA related antigens in surgically resected specimen. The expression of CEA mRNA in colon cancer and normal colon mucosa have been proved by Northern blot analysis (Cournoyer, 1988; Sato, 1988; Hinoda, 1991) , while its localisation throughout the cytoplasm of adenomas and carcinomas has been detected by in situ hybridisation (Higashide, 1990) . NCA, also detected in colon cancer tissues (Cournoyer, 1988; Chi, 1991) , was found to be the predominant member of the CEA family in normal lung and most of lung cancer tissues (Hasegawa, 1993) . The expression of CEA gene family in gastric cancer and normal gastric mucosa, however, has not been examined in detail to date.
Several attempts have been made in vivo and in vitro to assess the function of the CEA molecules. Adhesion molecules have provided insights into tumour invasion and metastasis (Liotta, 1991) . CEA is known to be one of the adhesion molecules and has been reported to cause homotypic aggregation of colorectal cancer cells (Benchimol, 1989) , while a systemic injection of CEA has been reported to enhance metastasis to the liver in an experimental model in athymic nude mice (Hobstetter, 1989) . These facts implicate some association of CEA with metastasis. On the other hand, induction of cell differentiation has been known to result in enhanced CEA mRNA levels in vitro (Toribara, 1989; Hauck, 1991) elucidated to date. We report here the analysis of mRNA expression of CEA and NCA in surgically resected gastrointestinal cancer tissues and adjacent normal mucosae by Northern blot analysis, and provide some new insights that might provide clues to the functions of CEA.
Materials and methods

Tissue preparation
The following tissues were obtained during surgery in Nagoya University Hospital, Nagoya, Japan, Komaki Municipal Hospital, Komaki City, Japan, and Nakatsugawa Municipal Hospital, Nakatsugawa City, Japan; 26 human gastric cancer tissues (18 with matching adjacent morphologically normal gastric mucosae, four with matching metastatic lymph nodes, two with matching liver metastases), three normal gastric mucosae from the patients with early gastric cancer (Table I) , and 14 colorectal cancer tissues (ten with matching adjacent mucosae, two with matching nodal metastases, and one with matching liver metastasis; Table II) . They were frozen in liquid nitrogen within 15 min of resection and stored at -80°C until use.
Cell line A gastric cancer cell line MKN45 was obtained from the Japanese Cancer Research Resources Bank and cultured in RPMI 1640 medium supplemented with 10% foetal calf serum.
cDNA probes The cDNA probe for CEA used in this study, CEA3, is a Pvu 1I-digested DNA fragment of the pCEA 55-2 clone (Oikawa, 1987) . It includes the first internal domain homologous to the internal domain of NCA cDNA ( Figure  1 ). Therefore, it detects a 2.9-kilobase transcript corresponding to NCA as well as the 4.2 and 3.5-kilobase transcripts corresponding to CEA (Sato, 1988) . The NCA-specific probe ( Figure 1 ) is an EcoRI-digested DNA fragment of the 3'-untranslated region of NCA clone 15 (Tawaragi et al., 1988) . A human beta actin probe (Nakajima-Iijima et al., 1985) was used as an internal control. Figure 2 . bThe histopathological classification based on the degree of differentiation was performed according to The General Rules for the Gastric Cancer Study (Japanese Research Society for Gastric Cancer). cPlasma CEA values were evaluated within a few days before the surgical resection (ngml-1). dmRNA levels of CEA and NCA are expressed in relation to the intensities of their expression in MKN45 designated as 100. Abbreviations: N = normal mucosa, Ca = cancer tissue, H = hepatic metastasis, L = lymph node metastasis. Table I. RNA extraction and Northern blot analysis Total RNA was extracted from the surgical specimen and the cell line by the procedure of Chomczynski (Chomczynski & Sacchi, 1987 The Northern blot analysis using the CEA and NCA cDNA probes revealed bands corresponding to CEA at 4.2 and 3.5-kb and a band corresponding to NCA at 2.9-kb in almost all specimens of gastric and colorectal malignancies (Figure 2 and 3). The number beneath each lane corresponds to the case number in Tables I and II. There was, however, a significant difference (U = 53.5, P <0.0005) between the CEA mRNA levels in adenocarcinomas of stomach (n = 27) and colon (n = 14) as quantitated by the imaging analyser ( Figure 4) ; the former being weaker than the latter. No significant difference in NCA gene expression on the other hand, was detected between the two groups (U = 95, P> 0.1).
Although the mRNA levels of CEA in gastric cancer specimens (n = 27) were apt to be variable as discussed later, they were significantly (U = 111, P <0.0005) elevated compared with the mRNA levels in normal gastric mucosae (n = 22). CEA mRNA expression was, however, weakly but distinctly detected in some of the morphologically normal gastric mucosa. CEA gene expression was almost invariably high in normal colon mucosae (n = 11), and no statistically significant difference (U = 61, P = 0.4) was found between these and the mRNA levels in colorectal cancer specimens (n= 14).
NCA expression (Figure 4) proved to be more specific to cancerous tissues than that of CEA. It was detected in most colon cancer specimens, and there was a significant difference (U = 22.5, P<0.05) in the mRNA levels between colorectal cancer (n = 12) and normal colon mucosae (n= 10). The NCA expression in the normal gastric mucosae (n = 20) was also significantly weaker (U = 26, P <0.0005) than the gastric cancer tissues (n = 26), often too weak to be detected.
Staging and histological classification
Staging was performed in accordance with The General Rules for TNM classification (International Union Against Cancer). Tissue specimens were promptly fixed in 10% formaldehyde, embedded in paraffin, and stained with hematoxylin and eosin. Tumour differentiation and degree of invasion were examined by the pathologists and histopathological classification was performed according to The General Rules for the Gastric Cancer Study (Japanese Research Society for Gastric Cancer, Kanehara Shuppan, Tokyo, Japan), and The General Rules for Clinical and Pathological Studies on Cancer of Colon, Rectum and Anus (Japanese Research Society for Cancer of Colon and Rectum, Kanehara Shuppan, Tokyo, Japan).
Plasma CEA values
The plasma CEA values of the patients were evaluated by a commercial assay kit (Wako Pure Chemical Industries, Osaka, Japan, cut-off value; 5 ng ml-') a few days prior to CEA gene expression and plasma CEA value There was a lack of correlation between the gene expression in malignant tissues and the plasma CEA values both in gastric (r = -0.056, P = 0.80) and colorectal (r =-0.021, P = 0.94) cancer.
CEA gene expression and metastasis
In gastric cancer, no significant overexpression of CEA was observed (U = 27.5, P = 0.37 between pNO and pNl, and U = 34, P = 0.29 between pNO and pN2) between cancer tissues with clinically detectable nodal metastasis (pNl :n = 6, and pN2:n = 14) and those without (pNO:n = 7). The same result (U = 68, P = 0.70) came from comparison between gastric cancer tissues with distant metastasis (n = 8) and those without (n = 19).
In colon cancer, too, the comparison of CEA gene expression between node positive (n = 6) and node negative (n = 8) cancer tissues (U = 26, P = 0.75), and cancer tissues with distant metastasis (n = 2) and those without (n = 12, U = 7, Figure 4 Left: The expression of CEA mRNAs in gastric mucosae (n = 22), gastric cancer specimen (n = 27), colorectal mucosae (n= 11), and colorectal cancer specimen (n = 14). The intensity of the major 3.5 Kb band of the cell line MKN45, determined by densitometric analysis with Fujix BAS2000 Imaging Analyzer was designated as 100, and the expression of the rest of the specimens were expressed in relation to MKN45. The bars denote mean + s.d. Right: The expression of NCA mRNAs in gastric mucosae (n = 20), gastric cancer tissues (n = 26), colorectal mucosae (n = 10), and colorectal cancer specimens (n = 12). The intensity of the 2.9 Kb transcript of the cell line MKN45 was designated as 100. Poor Mod + well Poor Mod + well Figure 5 The CEA and NCA mRNA levels (relative to those in MKN45 as described in the legend of Figures 4 and 5 ) of the gastric cancer tissues are shown in relation to the histopathological classification. The abbreviation por stands for poorly differentiated adenocarcinoma (n = 7), mod for moderately differentiated adenocarcinoma (n = 11) and well for well differentiated adenocarcinoma (n = 4), respectively. and moderately differentiated gastric cancers (n = 15) to exceed the poorly differentiated cancers (n = 8) in CEA gene expression although the probability was calculated to be of borderline statistical significance (U = 35,P = 0.055 has not yet been evaluated in detail.
In our series of Northern blot analyses, CEA gene expression of varied levels has been recognised in gastric cancer tissues. Expression was significantly weaker compared with the almost invariable overexpression found in colon cancer, but it still exceeded the mRNA levels in normal gastric mucosae which were faint in most and not detected in seven cases. However, distinct expression of CEA mRNA was evident in some samples of the normal mucosae, including that of case 8, a morphologically normal mucosa derived from a patient with an early gastric cancer.
The mRNA levels of NCA in colon cancer have been reported to be significantly elevated relative to the normal mucosa (Chi, 1991) On evaluating the contribution of CEA overexpression to metastasis, only the concomittant metastases found before or at the time of operation were taken into consideration in this study. Further periods of observation might allow the growth and detection as recurrences of micrometastases in the patients that we now diagnose as metastasis-free, and the results could then be different. At the moment, however, CEA was not found to be overexpressed in tumours with nodal or distant metastases compared with those without. Results such as those of case 3 or 11 in gastric cancer cast doubts to the role of CEA in some cases of metastasis formation, in spite of the encouraging in vivo study described earlier (Hostetter, 1988) .
The total lack of correlation between the plasma CEA and CEA gene expression deserves some considerations. The plasma value is known to correlate with the pattern of immunostaining performed with the CEA monoclonal antibody in colon cancer specimens Cellular differentiation induced by sodium butyrate (Toribara, 1989 ) and gamma-interferon (Hauck, 1991) , was reported to enhance CEA and NCA mRNA levels in human colon cancer cell lines. The levels of CEA released from the apical membranes into the medium rose in time-dependent manner when a colon cancer cell line, HT29-D4 was induced to differentiate by substituting galactose for glucose (Fantini, 1989) . Whether the induction of CEA and NCA is the cause or the result of the differentiation is unknown, but our results concerning the expression of the CEA family and histopathological classification of gastric cancer samples seem to coincide with these studies. Gastric cancers often exhibit a chaotic mixture of portions with different degrees of differentiation, and pathologists are required to select the tissue type which they find is predominant on which to base their histopathological diagnosis. This perhaps is one of the reasons for the relatively large variation in mRNA expression among specimens of the same histopathological diagnosis. Significant differences in expression of NCA mRNA were nevertheless observed between poorly and well or moderately differentiated adenocarcinomas. One of the reasons for the almost invariable detection of CEA mRNA in colon cancer might then be that poorly differentiated adenocarcinomas are relatively rare in colon, moderately to well differentiated cancers being the predominant histological types found in colorectal region. The only poorly differentiated colon cancer among our specimen (case 3), indeed, was shown to express a relatively low CEA mRNA level.
It is interesting to note that the expression of another much investigated adhesion molecule, E-cadherin, is known to correlate with differentiation in squamous cell carcinoma of head and neck (Schipper, 1991) although the correlation is less clear in gastric cancer (Shimoyama, 1991) . Further studies, though, will be needed to assess whether the CEA family, too, contributes to differentiation through its function as an adhesion molecule.
In conclusion, we postulate that (1) CEA mRNA level in gastric cancer is detectable but significantly lower than that of colon cancer, (2) the NCA mRNA is consistently overexpressed relative to normal mucosa both in gastric and colon cancer, (3) gene expression of CEA in cancer tissue does not correlate directly with serum CEA value in a patient and (4) association of the CEA family with differentiation has been demonstrated in gastric cancer specimens, although further studies will be needed to elucidate the true mechanism underlying this phenomenon.
